Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Hepatology. 2017 Jun 28;66(2):564–574. doi: 10.1002/hep.29219

Table 5.

Reclassification table comparing predicted 3-month risk of waitlist death estimated by MELDNa versus MELDNa and the frailty index, stratified by patients without (non-events) and with (events) waitlist death. Interior cells reflect the number of patients within the predicted risk categories. Pink cells indicate patients with an increased predicted risk of waitlist death estimated by MELDNa + frailty index versus MELDNa alone. Blue cells indicate patients with a decreased risk of death estimated by MELDNa + frailty index versus MELDNa alone. Yellow cells indicate no change in risk category when the frailty index is included in estimating risk.

Deaths/Delisting (n=107)

MELDNa risk category MELDNa + Frailty Index risk category
<5% 5–<10% 10%+ Total
<5% 50 7 4 61
5<10% 8 5 16 29
10%+ 0 2 15 17
Total 58 14 35 107

Non-deaths/Non-delistings (n=429)

MELDNa risk category MELDNa + Frailty Index risk category
<5% 5<10% 10%+ Total
<5% 287 24 3 314
5<10% 40 33 11 84
10%+ 5 6 20 31
Total 332 63 34 429